About AARDVARK THERAPEUTICS INC
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies to inhibit hunger and treat metabolic diseases. The company focuses on alleviating hunger through mechanisms such as activating bitter taste receptors to suppress hunger signals.
Development of novel small-molecule therapiesTargeting hunger-associated rare diseases and obesity-related conditionsActivation of bitter taste receptors (TAS2Rs) to trigger satiety hormonesClinical development of investigational drugs like ARD-101
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AARDVARK THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.